Axicabtagene ciloleucel in vivo expansion and treatment outcome in aggressive B-cell lymphoma in a real-world setting.
Ayuk FA, Berger C, Badbaran A, Zabelina T, Sonntag T, Riecken K, Geffken M, Wichmann D, Frenzel C, Thayssen G, Zeschke S, Kröger N, Fehse B.
Ayuk FA, et al. Among authors: berger c.
Blood Adv. 2021 Jun 8;5(11):2523-2527. doi: 10.1182/bloodadvances.2020003959.
Blood Adv. 2021.
PMID: 34100900
Free PMC article.